Anastasia Velentza

Anastasia Velentza

Company: Plexium

Job title: Senior Director Head of Discovery Technology


The Plexium Platform Expands the Repertory of E3 Ligases in TPD Drug Discovery 9:00 am

• Overview of the Plexium screening platform: Multiple detection readouts to identify monovalent degrader or molecular glue effects in cells • Case study of new E3 ligase discovery using monovalent degrader identified in protein degradation screening • E3 ligase redirection using RNAseq screeningRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.